Jacobus Ungerer

6.7k total citations
168 papers, 4.6k citations indexed

About

Jacobus Ungerer is a scholar working on Pharmacology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jacobus Ungerer has authored 168 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pharmacology, 32 papers in Epidemiology and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jacobus Ungerer's work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Acute Myocardial Infarction Research (23 papers) and Hormonal Regulation and Hypertension (20 papers). Jacobus Ungerer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (31 papers), Acute Myocardial Infarction Research (23 papers) and Hormonal Regulation and Hypertension (20 papers). Jacobus Ungerer collaborates with scholars based in Australia, New Zealand and United States. Jacobus Ungerer's co-authors include Brett McWhinney, Jason A. Roberts, Jeffrey Lipman, Carel Pretorius, Scott Briscoe, S. Bissbort, David W. Johnson, Megan Rossi, Katrina L. Campbell and Gloria Wong and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Jacobus Ungerer

162 papers receiving 4.6k citations

Peers

Jacobus Ungerer
Brett McWhinney Australia
Alexander A. Vinks United States
Joseph Bertino United States
Ron A. A. Mathôt Netherlands
Gregory L. Kearns United States
Eric P. Brass United States
Brett McWhinney Australia
Jacobus Ungerer
Citations per year, relative to Jacobus Ungerer Jacobus Ungerer (= 1×) peers Brett McWhinney

Countries citing papers authored by Jacobus Ungerer

Since Specialization
Citations

This map shows the geographic impact of Jacobus Ungerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacobus Ungerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacobus Ungerer more than expected).

Fields of papers citing papers by Jacobus Ungerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacobus Ungerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacobus Ungerer. The network helps show where Jacobus Ungerer may publish in the future.

Co-authorship network of co-authors of Jacobus Ungerer

This figure shows the co-authorship network connecting the top 25 collaborators of Jacobus Ungerer. A scholar is included among the top collaborators of Jacobus Ungerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacobus Ungerer. Jacobus Ungerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gwee, Amanda, Andrew C. Steer, Khampheng Phongluxa, et al.. (2024). Ivermectin therapy for young children with scabies infection: a multicentre phase 2 non-randomized trial. The Lancet Regional Health - Western Pacific. 49. 101144–101144. 1 indexed citations
3.
McWhinney, Brett, Jacobus Ungerer, Natalie Phillips, et al.. (2024). Serum Levels of Vitamin C and Thiamin in Children With Suspected Sepsis: A Prospective Observational Cohort Study. Pediatric Critical Care Medicine. 25(2). 171–176. 6 indexed citations
4.
Pretorius, Carel, Paulette Barahona, Jim McGill, et al.. (2023). Feasibility of Targeted Next-Generation DNA Sequencing for Expanding Population Newborn Screening. Clinical Chemistry. 69(8). 890–900. 5 indexed citations
5.
Heffernan, Aaron J., David T Yeung, Morgyn S. Warner, et al.. (2023). Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients. Antimicrobial Agents and Chemotherapy. 67(3). e0155022–e0155022. 3 indexed citations
6.
Heffernan, Aaron J., Fekade B. Sime, Steven C. Wallis, et al.. (2022). Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 66(6). e0218921–e0218921. 17 indexed citations
7.
Chang, Anne B., Keith Grimwood, Andrew Wilson, et al.. (2021). Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. SHILAP Revista de lepidopterología. 2 indexed citations
8.
Parker, Suzanne L., George John, Brett McWhinney, et al.. (2020). Kidney Transplant Recipient’s Perceptions of Blood Testing Through Microsampling and Venepuncture. Bioanalysis. 12(13). 873–881. 12 indexed citations
9.
Rawlins, Matthew, et al.. (2020). Pharmacokinetics of Ceftriaxone During Prolonged Intermittent Renal Replacement Therapy in a Patient with Child–Pugh B Cirrhosis and Ascites. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Gwee, Amanda, Stephen B. Duffull, Xiao Zhu, et al.. (2020). Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children. PLoS neglected tropical diseases. 14(12). e0008886–e0008886. 15 indexed citations
12.
Wong, Gloria, Fabio Silvio Taccone, Paola Villois, et al.. (2019). β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. Journal of Antimicrobial Chemotherapy. 75(2). 429–433. 43 indexed citations
13.
Goyal, Vikas, Keith Grimwood, Catherine A. Byrnes, et al.. (2018). Amoxycillin-clavulanate vs azithromycin for respiratory exacerbations of bronchiectasis in children - a multi-centre double blind non-inferiority randomised controlled trial. American Journal of Respiratory and Critical Care Medicine. 197. 1 indexed citations
14.
Wong, Gloria, Scott Briscoe, Brett McWhinney, et al.. (2018). Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures. Journal of Antimicrobial Chemotherapy. 73(11). 3087–3094. 128 indexed citations
15.
Wong, Gloria, et al.. (2017). Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy. International Journal of Antimicrobial Agents. 49(5). 589–594. 49 indexed citations
16.
Conway, Paul, Carel Pretorius, Jacobus Ungerer, et al.. (2015). Cortisol responses at baseline and after corticotropin in acute aneurysmal subarachnoid haemorrhage: a prospective study. Critical Care and Resuscitation. 17(1). 37–42. 1 indexed citations
17.
Irvine, Katharine M., Leesa Wockner, Mihir Shanker, et al.. (2015). Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
18.
Goupil, Rémi, et al.. (2015). Concomitant autonomous cortisol secretion by aldosterone-producing adenoma: the utility of plasma metadrenaline to assess lateralization during adrenal venous sampling. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
19.
Barraclough, Katherine A., Nicole M. Isbel, Katie J. Lee, et al.. (2012). NR1I2 Polymorphisms Are Related to Tacrolimus Dose-Adjusted Exposure and BK Viremia in Adult Kidney Transplantation. Transplantation. 94(10). 1025–1032. 43 indexed citations
20.
Cohen, Jeremy, Carel Pretorius, Jacobus Ungerer, et al.. (2011). Serial Changes in Plasma Total Cortisol, Plasma Free Cortisol, and Tissue Cortisol Activity in Patients With Septic Shock. Shock. 37(1). 28–33. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026